Arlington Asset Investment is an investment firm that focuses on acquiring and holding a levered portfolio of residential mortgage-backed securities (MBS), consisting of agency MBS and private-label MBS. Agency MBS include residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by a U.S. government agency or government sponsored enterprise (GSE), such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. government agency, such as the Government National Mortgage Association. Private-label MBS include residential MBS that are not guaranteed by a GSE or the U.S. government.

At Home Group is a holding company. Through its subsidiaries, the company is a home decor superstore. The company's product mix includes home furnishings, which consists of accent furniture, furniture, mirrors, patio cushions, rugs and wall art. Accent decor consists of artificial flowers and trees, bath, bedding, candles, garden and outdoor decor, holiday accessories, home organization, pillows, pottery, vases and window treatments. The company operates its stores primarily in the South Central, Southeastern, Mid-Atlantic and Midwestern regions of the U.S. In addition, the company operates a distribution center and warehouse premises in Texas, which services its stores, and a second distribution center in Pennsylvania.

Blucora is a provider of technology-enabled financial solutions. The company has two reportable segments: Wealth Management and Tax Preparation. The Wealth Management business consists of the operations of Avantax Wealth Management, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and their clients and is a tax-focused independent broker-dealer. The Tax Preparation business consists of the operations of TaxAct, Inc., which provides digital do-it-yourself tax preparation solutions for consumers, small business owners and tax personnel through its website www.TaxAct.com.

Blue Apron provides recipes, ingredients, and cooking techniques. The company's products include: meals, which consist of a Two-Serving Plan that serves two people, and a Family Plan that serves four people; wine, through Blue Apron Wine delivery service to deliver wines, including red and white wines (and roses, depending on the season), tasting notes, pairing tips, and the story behind each wine; market, which features a selection of cooking tools, utensils, and pantry items through its e-commerce marketplace, Blue Apron Market; and digital experience, which provides how-to cooking videos, stories about its suppliers, and its collection of various recipes that customers can access on their own.

Cassava Sciences is a clinical-stage drug development company. The company focuses on developing new product candidates and to guide these through various regulatory and development pathways in preparation for their potential commercialization. The company's clinical-stage biopharmaceutical assets include: PTI-125, which is its product candidate for the treatment of Alzheimer's disease; and PTI-125Dx, which it is developing as a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company owns worldwide rights to PTI-125 and PTI-125Dx, without royalty obligations to any third party.

CB Financial Services is bank holding company. Through its wholly owned subsidiary, Community Bank (the Bank), the company provides residential and commercial real estate loans, commercial and industrial loans, and consumer loans as well as a variety of deposit products for individuals and businesses in its market area. In addition, the Bank is the sole shareholder of Exchange Underwriters, Inc., a wholly-owned subsidiary that is an independent insurance agency that provides property and casualty, commercial liability, surety and other insurance products.

Chatham Lodging Trust is a real estate investment trust. All of the company's assets are held by, and all operations are conducted through its operating partnership, Chatham Lodging, L.P., which leases the company's wholly owned hotels to taxable REIT subsidiary lessees. The company's wholly owned hotels include hotels that operate under the Residence Inn by Marriott? brand and Homewood Suites by Hilton? brand, as well as hotels that operate under the Courtyard by Marriott? brand, the Hampton Inn or Hampton Inn and Suites by Hilton? brand, the Hilton Garden Inn by Hilton? brand, the SpringHill Suites by Marriott? brand, the Hyatt Place? brand and all suite hotels that operate under the Embassy Suites brand?.

City Office REIT is engaged in acquiring, owning and operating office properties located in the Southern and Western U.S. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, San Diego and Tampa.

Core Molding Technologies operates in the composites market in a family of products known as structural composites. Structural composites are combinations of resins and reinforcing fibers (typically glass or carbon) that are molded to shape. The company is a manufacturer of sheet molding compound (SMC) and molder of thermoset and thermoplastic products. The company focuses on moldings and provides processes, including compression molding of SMC, glass mat thermoplastics, bulk molding compounds and direct long fiber thermoplastic, spray-up, hand-lay-up, resin transfer molding, structural foam and structural web injection molding, and reaction injection molding, utilizing dicyclopentadiene technology.

Corporate Office Properties Trust is a real estate investment trust. Corporate Office Properties, L.P. (COPLP) and subsidiaries is the entity through which the company, the sole general partner of COPLP, conducts almost all of its operations and owns almost all of its assets. The company owns, manages, leases, develops and selectively acquires office and data center properties. The majority of the company's portfolio is in locations that support the United States Government and its contractors that engaged in national security, defense and information technology related activities servicing. The company also owns office properties in select urban/urban-like submarkets in the Greater Washington, DC/Baltimore region.

Entercom Communications is a holding company. Through its subsidiaries, Co, is a media and entertainment company primarily engaged in the sale of advertising time to local, regional and national advertisers and national network advertisers who purchase commercials in varying lengths. The company focuses on station-related digital product suites, which allow for audience interaction and participation, and integrated digital advertising solutions. The company's stations are classified by their format, such as news, sports, talk, classic rock, urban, adult contemporary, alternative and country, among others.

Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing the company's patented piezo-print delivery technology, branded the Optejet?. The company's MicroStat is a fixed combination formulation of phenylephrine-tropicamide for mydriasis (pupil dilation). MicroPine is a topical therapy for the treatment of progressive myopia. MicroProst is a latanoprost formulation for lowering intraocular pressure in patients with ocular hypertension, primary open angle glaucoma, and chronic angle closure glaucoma. MicroTears is the company's over-the-counter product candidate for hyperemia (red eye), pruritis (itch) and dry eye.

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

Hartford Financial Services Group is a holding company. Through its subsidiaries, the company provides property and casualty insurance, group benefits insurance and services, and mutual funds and exchange-traded products. The company has five segments: Commercial Lines, which provides automobile, property, general liability, and marine coverages; Personal Lines, which provides automobile and homeowners coverages; Property and Casualty Other Operations, which provides group life, group disability, and other products; and Hartford Funds, which provides mutual fund, exchange-traded products, and Talcott Resolution life and annuity separate accounts.

Highwoods Properties is a real estate investment trust. The company owns, develops, acquires, leases and manages properties primarily in the business districts of Atlanta, Charlotte, Nashville, Orlando, Pittsburgh, Raleigh, Richmond and Tampa. The company's primary business is the operation, acquisition and development of office properties. The company conducts its activities through its subsidiary, Highwoods Realty Limited Partnership. The company provides a line of real estate services to its customers. The company provides its customers with services such as build-to-suit construction and space modification, including tenant improvements and expansions.

Kingsway Financial Services is a holding company. Through its subsidiaries, Co. operates as a merchant bank engaged in the property and casualty insurance business. Co. operates three segments: Insurance Underwriting, which markets automobile insurance products that provide coverage in three main areas: liability, accident benefits and physical damage; Insurance Services, which includes IWS Acquisition Corporation, a licensed motor vehicle service agreement company, and Trinity Warranty Solutions LLC, a provider of warranty products and maintenance support; and Leased Real Estate, which includes Co.'s subsidiary, CMC Industries, Inc., that owns a parcel of real property located in Texas.

Kodiak Sciences is a clinical stage biopharmaceutical company focusing on therapeutics to treat chronic, high-prevalence retinal diseases. The company's main product candidate is KSI-301, a biologic therapy built with the company's antibody biopolymer conjugate platform, which is designed to maintain drug levels in ocular tissues. KSI-301 is used to treat patients with wet age-related macular degeneration, diabetic retinopathy, including diabetic macular edema, and macular edema due to retinal vein occlusion. The company has applied its antibody biopolymer conjugate platform to develop additional product candidates beyond KSI-301, including KSI-501, its bispecific anti-IL-6/VEGF bioconjugate.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

Safety Insurance Group is a holding company. Through its subsidiaries, the company is a provider of private passenger, commercial automobile and homeowners insurance in Massachusetts. The company's product lines include: Private Passenger Automobile, which provides coverage for bodily injury and property damage to others, no-fault personal injury coverage for the insured/insured's car occupants, and physical damage coverage for an insured's own vehicle for collision or other perils; Commercial Automobile, which provides insurance for commercial vehicles used for business purposes; and Inland Marine, which provides inland marine coverage as an endorsement for all homeowners and business owner policies.

Saul Centers operates as a real estate investment trust. The company, which conducts its activities through its subsidiaries, the Saul Holdings Limited Partnership and two subsidiary limited partnerships, engages in the ownership, operation, management, leasing, acquisition, renovation, expansion, development and financing of community and neighborhood shopping centers and mixed-used properties, primarily in the Washington, DC/Baltimore metropolitan area. The company's properties consist of shopping center properties, mixed-use properties, which are comprised of office, retail and multi-family residential uses and development properties.

ServiceSource International is engaged in outsourced customer success and revenue growth solutions. The company's solutions span the lifecycle of its clients' customers, from landing new customers (Co. provides lead generation, inside sales, and outsourced sales operations services), adoption (Co. provides customer onboarding and customer success management services), expansion (Co. provides cross-sell and upsell, warranty conversion, account-based marketing and channel recruitment and enablement) and renewals (Co. provides renewals management services, including the sale of maintenance and support service contracts for the products used by its clients' end-users).

Stellus Capital Investment is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments in middle-market companies.

Tejon Ranch is a real estate development and agribusiness company. The company's segments are: Real Estate-Commercial/Industrial, which is involved in building, land lease activities, and land and building sales; Real Estate-Resort/Residential, which is involved in the land entitlement and development process internally and through a joint venture; mineral resources, which includes oil and gas royalty leases, rock and aggregate mining leases, a lease with National Cement and sales of water; Farming Operations, which is engaged in the sale of wine grapes, almonds and pistachios; and Ranch Operations, which consists of game management and ancillary land uses such as grazing leases and filming.

TPG RE Finance Trust is a holding company. Through its subsidiaries, the company conducts its operations as a real estate investment trust. The company originates and acquires a portfolio of commercial real estate-related assets consisting primarily of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States and, to a lesser extent, commercial mortgage-backed securities. The company is externally managed and advised by TPG RE Finance Trust Management, L.P.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.

TravelCenters of America is engaged in the operation and franchise of travel center and standalone restaurant locations. The company's business included travel centers in several states in the U.S., primarily along the U.S. interstate highway system, and the province of Ontario, Canada, operated primarily under the TravelCenters of America, TA, TA Express, Petro Stopping Centers and Petro brand names. The company's travel centers provides a range of products and services, including diesel fuel and gasoline, as well as nonfuel products and services such as truck repair and maintenance services, full service restaurants, quick service restaurants, and various customer amenities.

Wheeler Real Estate Investment Trust is a holding company. The company is a self-managed commercial real estate investment company focused on owning, leasing and operating retail properties with a primary focus on grocery-anchored centers. The company serves as the general partner of Wheeler REIT, L.P. (the Operating Partnership). Substantially, all of the company's assets are held by, and all of its operations are conducted through, its Operating Partnership. The company's owned properties are located in Virginia, North Carolina, South Carolina, Florida, Georgia, Kentucky, Oklahoma, Tennessee, Alabama, New Jersey, Pennsylvania and West Virginia.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.